| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,185 | 22,343 | 21,575 | 26,687 | | Cost of Revenue | 10,001 | 11,012 | 9,880 | 13,607 | | | Gross Profit | 12,184 | 11,331 | 11,695 | 13,080 | | | Operating Expenses | | Research Development | 2,869 | 2,871 | 2,809 | 2,481 | | Selling General and Administrative | 6,998 | 7,324 | 7,031 | 7,094 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,317 | 1,136 | 1,855 | 3,505 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 213 | 251 | 196 | 1,565 | | Earnings Before Interest And Taxes | 2,530 | 1,387 | 2,051 | 5,070 | | Interest Expense | 3 | 3 | 4 | 4 | | Income Before Tax | 2,527 | 1,384 | 2,047 | 5,066 | | Income Tax Expense | 610 | 374 | 655 | 1,700 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,917 | 1,010 | 1,392 | 3,366 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,917 | 1,010 | 1,392 | 3,366 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,917 | $1,010 | $1,392 | $3,366 |
|
0.00% Nasdaq 
0.35%
Income Statement
